| Literature DB >> 15686268 |
George S Drummond1, Attallah Kappas.
Abstract
The uses of synthetic heme analogues that are competitive inhibitors of heme oxygenase, the rate-limiting enzyme in the production of bilirubin, represent a novel means of controlling severe hyperbilirubinemia in the newborn. The logic of this approach and the use of stannsoporfin (tin mesoporphyrin) as the compound of choice are discussed.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15686268 DOI： 10.1053/j.semperi.2004.09.004
Source DB: PubMed Journal: Semin Perinatol ISSN： 0146-0005 Impact factor: 3.300